Search Results
Dec 09, 2025, 08:00 ET Oral Presentation at ASH 2025 Shows Canopy RTM Cuts Infection-Related Hospitalizations by 52% and Generates Nearly $1M in Annual Savings per 1,000 Patients
monitoring provides will matter even more as novel therapies with unique toxicities and infection risks continue to expand, such as bispecific T-cell engagers and CAR T-cell therapies," said James Essell, MD, Medical Director of the Center for Cancer and Cellular Therapy at Oncology Hematology Care (OHC) and
More news about: Canopy
Dec 09, 2025, 08:00 ET Alaska Airlines is now selling tickets for new nonstop flights between Seattle and London Heathrow on Boeing 787 Dreamliner aircraft
movies and classic films, as well as dozens of TV shows.Alaska is set to bring ultra-fast Wi-Fi to our 787-9 aircraft in fall 2026, thanks to T-Mobile and powered by Starlink. The service will be free for Atmos Rewards members.With London flights now available for booking at
More news about: Alaska Airlines
Dec 09, 2025, 07:44 ET Unprecedented results from the Phase 3 MajesTEC-3 study support TECVAYLI® plus DARZALEX FASPRO® as a potential standard of care as early as second line for patients with relapsed/refractory multiple myeloma
TECVAYLI®TECVAYLI® (teclistamab-cqyv) is a first-in-class, bispecific T-cell engager antibody therapy that uses innovative science to activate the immune system by binding to the CD3 receptor expressed on the surface of T-cells and to the B-cell maturation antigen (BCMA) expressed on the surface
More news about: Johnson & Johnson
Dec 09, 2025, 07:00 ET Saluda Medical Raises $150M USD to Fuel Growth Following ASX IPO
within the Prospectus, existing securityholders include Wellington Management, Fidelity Management & Research Company, funds and accounts advised by T. Rowe Price Associates, Inc., TPG Life Sciences Innovations, Redmile Group, LLC, amongst others."This IPO and capital raise mark an important moment
More news about: Saluda Medical
Dec 09, 2025, 05:00 ET Dizal Showcases its Strong Hematology Pipeline with New Data from Golidocitinib and Birelentinib at ASH 2025
demonstrated compelling clinical activity with a favorable safety profile in heavily pretreated relapsed or refractory T-cell and NK-cell large granular lymphocyte leukemia (r/r T-LGLL) patients. Results from a prospective study showed an ORR of 92.3% and a CR rate of 61.15%. Additionally, the study reported
More news about: Dizal Pharmaceutical
Dec 09, 2025, 01:39 ET CGTN : après la tragédie, Hong Kong s'unit pour reconstruire
consécutifs, Wong et plusieurs autres chauffeurs ont fait la navette gratuitement. « Nous commençons à huit heures et ne nous arrêtons tard dans la journée », a-t-il déclaré. « Oui, c'est un manque à gagner, mais il est plus important d'aider les gens. »Entre les nombreux volontaires et le flot de dons de
More news about: CGTN
Dec 09, 2025, 01:19 ET Voranigo® (Vorasidenib) von Servier erhält Prix Galien Awards in mehreren Regionen
den Bent, M. J., Blumenthal, D. T., Touat, M., Peters, K. B., Clarke, J., Mendez, J., Yust-Katz, S., Welsh, L., Mason, W. P., Ducray, F., Umemura, Y., Nabors, B., Holdhoff, M., Hottinger, A. F., Arakawa, Y., Sepulveda, J. M., Wick, W., Soffietti, R., ... Cloughesy, T. F. (2023). Vorasidenib in idh1-
More news about: Servier
Dec 09, 2025, 01:01 ET Servier の Voranigo®（ボラシデニブ）が複数地域でプリ・ガリアン賞を受賞
van den Bent, M. J., Blumenthal, D. T., Touat, M., Peters, K. B., Clarke, J., Mendez, J., Yust-Katz, S., Welsh, L., Mason, W. P., Ducray, F., Umemura, Y., Nabors, B., Holdhoff, M., Hottinger, A. F., Arakawa, Y., Sepulveda, J. M., Wick, W., Soffietti, R., … Cloughesy, T. F.（2023年）IDH1 または IDH2 変異を有する低悪性度膠芽腫におけるボラシデニブNew
More news about: Servier
Dec 09, 2025, 00:04 ET EpiVax und Wissenschaftler der FDA veröffentlichen neue Erkenntnisse zu den Immunogenitätsrisiken von peptidbezogenen Verunreinigungen in generischem Teriparatid
die möglicherweise neue „T-Zell-Epitope" generieren.Die Studie bewertet systematisch Teriparatid und mehrere theoretische oder beobachtete Verunreinigungen unter Verwendung der orthogonalen Methoden des PANDA-Ansatzes von EpiVax: In-silico-Bewertung (unter Verwendung der T-Zell-Epitop-Vorhersage-
More news about: EpiVax, Inc.
Dec 08, 2025, 20:59 ET 【直擊2025 ASH】亞盛醫藥耐立克®治療TKI耐藥/不耐受CML-CP患者的註冊II期研究4年隨訪數據亮相，長期療效和安全性優勢再獲證實
(TKI)-resistant chronic-phase chronic myeloid leukemia (CML-CP) in a registrational randomized phase 2 trial: up to 4-year follow-up including patients without T315I mutations在一項隨機、註冊性2期臨床試驗中奧雷巴替尼（HQP1351）對酪氨酸激酶抑制劑（TKI）耐藥的慢性期慢性髓系白血病（CML-CP
More news about: 亞盛醫藥
Dec 08, 2025, 18:56 ET Alors que le nombre de décès d'enfants devrait augmenter pour la première fois au cours de ce siècle, la Fondation Gates exhorte les dirigeants mondiaux à cibler les ressources limitées là où elles permettent de sauver le plus de vies.
développe des outils de nouvelle génération pour lutter contre le paludisme. « L'éradication du paludisme n'est pas seulement possible, elle est urgente », a-t-elle déclaré. « Nous, chercheurs africains, le savons et nous montrons la voie à suivre. »En Inde, le Dr Naveen Thacker, pédiatre, a souligné
More news about: Gates Foundation
Dec 08, 2025, 16:30 ET John Stankey to Update Shareholders at UBS Global Media & Communications Conference on Dec. 9
2025-2027.AT&T is pleased with how the Mobility business is performing and continues to expect seasonally lower postpaid phone ARPU in the fourth quarter. The Company continues to expand access to AT&T Fiber – the fastest, top-rated internet nationwide3 – and AT&T Internet Air.
More news about: AT&T
Dec 08, 2025, 16:15 ET Farmer Mac Names Matthew M. Pullins as EVP - Chief Financial Officer and Treasurer
financial expertise, operational leadership, and personal connection to rural America makes him a natural fit for our company and our mission," said Bradford T. Nordholm, Chief Executive Officer of Farmer Mac. "Matt brings a strategic mindset, a proven track record of strong execution, and a values-driven leadership
More news about: Farmer Mac
Dec 08, 2025, 16:01 ET MediaTek amplia a liderança no mercado de processadores para smartphones no Brasil e na América Latina
modelos da série Xiaomi 15T, lançados recentemente no Brasil. "A série Xiaomi 15T oferece desempenho robusto e gerenciamento térmico eficiente para atender às demandas dos usuários atuais. O Xiaomi 15T Pro funciona com o chipset MediaTek Dimensity 9400+, enquanto o Xiaomi 15T é alimentado pelo MediaTek
More news about: MediaTek
Dec 08, 2025, 15:33 ET EpiVax et les scientifiques de la FDA publient de nouvelles informations sur les risques d'immunogénicité des impuretés liées aux peptides dans le tériparatide générique
de cellules T ».L'étude évalue systématiquement le tériparatide et plusieurs impuretés théoriques ou observées en utilisant les méthodes orthogonales de l'approche PANDA d'EpiVax : évaluation in silico (à l'aide d'outils de prédiction et de caractérisation des épitopes des cellules T, EpiMatrix®
More news about: EpiVax, Inc.
Dec 08, 2025, 14:00 ET EpiVax and FDA Scientists Publish New Insights on Immunogenicity Risks of Peptide-Related Impurities in Generic Teriparatide
sequence changes with the potential to generate new "T-cell epitopes".The study systematically evaluates teriparatide and several theoretical or observed impurities using the orthogonal methods of EpiVax's PANDA approach: in silico assessment (leveraging T-cell epitope prediction and characterization
More news about: EpiVax, Inc.
Dec 08, 2025, 13:23 ET EpiVax and FDA Scientists Publish New Insights on Immunogenicity Risks of Peptide-Related Impurities in Generic Teriparatide
sequence changes with the potential to generate new "T-cell epitopes".The study systematically evaluates teriparatide and several theoretical or observed impurities using the orthogonal methods of EpiVax's PANDA approach: in silico assessment (leveraging T-cell epitope prediction and characterization
More news about: EpiVax, Inc.
Dec 08, 2025, 12:00 ET Sumitomo Pharma America Presents New Investigational Data on Enzomenib and Nuvisertib at the 2025 American Society of Hematology Annual Meeting and Exposition
doi:10.1021/acs.jmedchem.8b00071Hernández-Boluda JC, Czerw T. Transplantation algorithm for myelofibrosis in 2022 and beyond. Best Pract Res Clin Haematol. 2022;35(2):101369. doi:10.1016/j.beha.2022.101369Cierpicki T, Grembecka J. Challenges and opportunities in targeting the menin-MLL
More news about: Sumitomo Pharma America
Dec 08, 2025, 11:30 ET MJFF Initiates Funding for Emerging Therapeutic Targets in Parkinson's Disease
project data through of our T2T Target Explorer platform, the field now has a transparent, shared view of where the most compelling therapeutic possibilities lie and where we can make the greatest impact together."As part of this next phase, MJFF is also releasing T2T's first public set of target
More news about: The Michael J. Fox Foundation for Parkinson's Research
Dec 08, 2025, 11:13 ET Children's Hospital of Philadelphia Researchers Identify Concerning Increase in Newborns Not Receiving Preventative Vitamin K Shots
MPH, a study author and attending neonatologist at CHOP.Dr. Scott's time was supported by a National Institutes of Health training grant (T32HD060550) and co-author Dr. Sara Handley's time by the National Institute of Child Health and Human Development Grant (K23HD109426).Scott et al. "Trends
More news about: Children's Hospital of Philadelphia
Dec 08, 2025, 11:00 ET Prominent Energy and Infrastructure M&A and Private Equity Partner Joins Latham's Market-Leading Practice in Texas
our oil and gas capabilities in Texas and will play a key role in solidifying our market-leading position in energy and infrastructure," added Justin T. Stolte, Global Chair of the firm's Energy & Infrastructure Group.Heasley also advises on joint ventures, DrillCo arrangements, tax equity
More news about: Latham & Watkins LLP
Dec 08, 2025, 10:00 ET Carolyn Bertozzi returns to Lilly board of directors
her back as we work to deliver more breakthrough medicines to patients."Currently serving as the Baker Family director of Sarafan ChEM-H, Anne T. and Robert M. Bass professor in the School of Humanities and Sciences and professor, by courtesy, of Chemical and Systems Biology and of Radiology at
More news about: Eli Lilly and Company
Dec 08, 2025, 09:10 ET T. ROWE PRICE'S INAUGURAL GLOBAL RETIREMENT SURVEY FINDS ONE-THIRD OF SAVERS EXPECT TO WORK IN RETIREMENT
upon source of advice worldwide."As we continue to expand our global reach, T. Rowe Price remains focused on turning insights into action," said Michael Davis, head of global retirement strategy at T. Rowe Price. "These findings will shape the solutions we develop and guide how we partner
More news about: T. Rowe Price Group
Dec 08, 2025, 09:07 ET PrimeXBT Empowers the Future through Education in South Africa
can afford the high risk of losing your money. The Company does not accept clients from the Restricted Jurisdictions as indicated on its website / T&Cs. Some products and services, including MT5, may not be available in your jurisdiction. The applicable legal entity and its respective products and
More news about: PrimeXBT
Dec 08, 2025, 09:01 ET Pacsun Drops Exclusive Fashion Line with The Metropolitan Museum of Art for the Holidays
Fairytale Mesh Long Sleeve Top create artsy, elevated looks for parties or evening outings. Everyday pieces like the flattering Modelbüch Skimmer T-Shirt and adorable
More news about: Pacsun